Management of NCD in low- And middle-income countries

Global Heart

Volumn 9, Issue 4, 2014, Pages 431-443

  Checkley, William ^a,b,c   Ghannem, Hassen ^d   Irazola, Vilma ^e   Kimaiyo, Sylvester ^f,g   Levitt, Naomi S ^h,i   Miranda, J Jaime ^b,j   Niessen, Louis ^b,k,l   Prabhakaran, Dorairaj ^m,n   Rabadán Diehl, Cristina ^o,p   Ramirez Zea, Manuel ^q   Rubinstein, Adolfo ^e   Sigamani, Alben ^r   Smith, Richard ^s   Tandon, Nikhil ^t   Wu, Yangfeng ^u   Xavier, Denis ^r   Yan, Lijing L ^u,v   GRAND South Network, ^w   National Heart, Lung, and Blood Institute Centers of Excellence, ^w  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^d FARHAT HACHED HOSPITAL   (Tunisia)

^e INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^f MOI UNIVERSITY   (Kenya)

^g MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^h Chronic Diseases Initiative in Africa   (South Africa)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^k INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^l LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^m CENTRE FOR CHRONIC DISEASE CONTROL   (India)

ⁿ PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^o NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^p U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^q Institute of Nutrition of Central America and Panama Guatemala   (Guatemala)

^r ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^s Civitas   (United Kingdom)

^t ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^u PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^v DUKE KUNSHAN UNIVERSITY   (China)

^w NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE SURVEILLANCE; HEALTH EDUCATION; HUMAN; INCOME; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SCREENING; SECONDARY PREVENTION; SELF CARE; SMOKING CESSATION; SYSTEMATIC REVIEW (TOPIC); CARDIOVASCULAR DISEASES; DEVELOPING COUNTRY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STROKE;

CARDIOVASCULAR DISEASES; DEVELOPING COUNTRIES; DIABETES MELLITUS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STROKE;

EID: 84920859724     PISSN: 22118160     EISSN: 22118179     Source Type: Journal    
DOI: 10.1016/j.gheart.2014.11.003     Document Type: Review

References (185)

1. World Health Organization. Global Status Report on Non-Communicable Diseases 2010. Geneva, Switzerland: World Health Organization; 2011.
2. Institute of Medicine. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington, DC: National Academies Press; 2010.
3. United Nations. General Assembly resolution on prevention and control of non-communicable diseases (A/RES/64/265). New York: United Nations; 2010.
4. National Heart, Lung, and Blood Institute. UnitedHealth and NHLBI collaborating centers of excellence. Available at: http://www.nhlbi.nih.gov/about/globalhealth/centers/index.htm. Accessed November 18, 2014.
5. Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011;377:568-77.
6. Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health 2008;13:1225-34.
7. The NCD Alliance. Proposed outcomes document for the United Nations High-Level Summit on Non-Communicable Diseases. Available at: http://www.ncdalliance.org/sites/default/files/rfiles/NCD%20Alliance%20Proposed%20Outcomes%20Document%20for%20the%20UN%20High-Level%20Summit.pdf. Accessed November 18, 2014.
8. Council of Ministers of Health of Central America and Dominican Republic. Declaration of Antigua Guatemala: united to stop the epidemic of chronic non-communicable diseases in Central America and Dominican Republic. Available at: http://sicasalud.net/sites/default/files/3.1.%20Declaratoria%20ECNT%20XXXIV%20COMISCA%20junio%202011.pdf. Accessed November 18, 2014.
9. Ebrahim S, Pearce N, Smeeth L, et al. Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med 2013;10:e1001377.
10. Dowse GK, Gareeboo H, Alberti KG, et al, for the Mauritius Non-Communicable Disease Study Group. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the Non-Communicable Disease Intervention Programme in Mauritius. BMJ 1995;311:1255-9.
11. World Health Organization. From Burden to "Best Buys ": Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries. Geneva, Switzerland: World Health Organization; 2011.
12. Cappuccio FP, Kerry SM, Micah FB, Plange-Rhule J, Eastwood JB. A community programme to reduce salt intake and blood pressure in Ghana [ISRCTN88789643]. BMC Public Health 2006;6:13.
13. China Salt Substitute Study Collaborative Group. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens 2007;25:2011-8.
14. Huang S, Hu X, Chen H, et al. The positive effect of an intervention program on the hypertension knowledge and lifestyles of rural residents over the age of 35 years in an area of China. Hypertens Res 2013;4:503-8.
15. Jafar TH, Islam M, Hatcher J, et al. Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial. BMJ 2010;340:c2641.
16. Sarrafzadegan N, Azadbakht L, Mohammadifard N, et al. Do lifestyle interventions affect dietary diversity score in the general population? Public Health Nutr 2009;12:1924-30.
17. Jafar TH, Hatcher J, Poulter N, et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med 2009;151:593-601.
18. Kar SS, Thakur JS, Jain S, Kumar R. Cardiovascular disease risk management in a primary health care setting of north India. Indian Heart J 2008;60:19-25.
19. Suhrcke M, Boluarte TA, Niessen L. A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries. BMC Public Health 2012;12:2.
20. Revill P, Sculpher M. Cost effectiveness of interventions to tackle non-communicable diseases. BMJ 2012;344:d7883.
21. Chisholm D, Baltussen R, Evans DB, et al. What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia? BMJ 2012;344:e586.
22. Ortegon M, Lim S, Chisholm D, Mendis S. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012;344:e607.
23. Vartiainen E, Laatikainen T, Peltonen M, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39:504-18.
24. The HEALTHY. Study Group. A school-based intervention for diabetes risk reduction. N Engl J Med 2010;363:443-53.
25. The World Bank, Human Development Unit, East Asia and Pacific Region. Toward a healthy and harmonious life in China: stemming the rising tide of non-communicable diseases. Available at: http://www.worldbank.org/research/2011/07/14639951/toward-healthy-harmonious-life-china-stemming-rising-tide-non-communicable-diseases#. Accessed November 18, 2014.
26. Gupta N, Goel K, Shah P, Misra A. Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev 2012;33:48-70.
27. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-Up Study cohort. Lancet 2008;371:923-31.
28. Mendis S, Mohan V. Non-laboratory-based prediction of cardiovascular risk. Lancet 2008;371:878-9.
29. Wald NJ, Simmonds M, Morris JK. Screening for future cardiovascular disease using age alone compared with multiple risk factors and age. PLoS One 2011;6:e18742.
30. Starfield B. Primary Care: Balancing Health Needs, Services and Technology. New York: Oxford University Press; 1998.
31. Frenk J, Chen L, Bhutta ZA, et al. Health professionals for a new century: transforming education to strengthen health systems in an interdependent world. Lancet 2010;376:1923-58.
32. Kengne AP, Awah PK, Fezeu LL, Sobngwi E, Mbanya JC. Primary health care for hypertension by nurses in rural and urban sub-Saharan Africa. J Clin Hypertens (Greenwich) 2009;11:564-72.
33. Gill GV, Price C, Shandu D, Dedicoat M, Wilkinson D. An effective system of nurse-led diabetes care in rural Africa. Diabet Med 2008;25:606-11.
34. Grone O, Garcia-Barbero M. Integrated care: a position paper of the WHO European Office for Integrated Health Care Services. Int J Integr Care 2001;1:e21.
35. Hickman M, Drummond N, Grimshaw J. A taxonomy of shared care for chronic disease. J Public Health Med 1994;16:447-54.
36. Starfield B. William Pickles Lecture. Primary and specialty care interfaces: the imperative of disease continuity. Br J Gen Pract 2003;53:723-9.
37. Smith SM, Allwright S, O'Dowd T. Effectiveness of shared care across the interface between primary and specialty care in chronic disease management. Cochrane Database Syst Rev 2007;3:CD004910.
38. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
39. Witmer A, Seifer SD, Finocchio L, Leslie J, O'Neil EH. Community health workers: integral members of the health care work force. Am J Public Health 1995;85:1055-8.
40. Farzadfar F, Murray CJ, Gakidou E, et al. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet 2012;379:47-54.
41. Habibzadeh F. The control of non-communicable diseases in rural Iran. Lancet 2012;379:6-7.
42. Walsh JM, Sundaram V, McDonald K, Owens DK, Goldstein MK. Implementing effective hypertension quality improvement strategies: barriers and potential solutions. J Clin Hypertens (Greenwich) 2008;10:311-6.
43. Brownstein JN, Bone LR, Dennison CR, Hill MN, Kim MT, Levine DM. Community health workers as interventionists in the prevention and control of heart disease and stroke. Am J Prev Med 2005;29:128-33.
44. Brownstein JN, Chowdhury FM, Norris SL, et al. Effectiveness of community health workers in the care of people with hypertension. Am J Prev Med 2007;32:435-47.
45. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998;51:367-75.
46. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296:427-40.
47. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006;166:2314-21.
48. McAlister FA, Lawson FM, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001;323:957-62.
49. Free C, Knight R, Robertson S, et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet 2011;378:49-55.
50. Wei J, Hollin I, Kachnowski S. A review of the use of mobile phone text messaging in clinical and healthy behaviour interventions. J Telemed Telecare 2011;17:41-8.
51. Free C, Phillips G, Galli L, et al. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med 2013;10:e1001362.
52. Free C, Phillips G, Galli L, et al. The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Med 2013;10:e1001363.
53. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 2011;57:29-38.
54. Kim J, Han HR, Song H, Lee J, Kim KB, Kim MT. Compliance with home blood pressure monitoring among middle-aged Korean Americans with hypertension. J Clin Hypertens (Greenwich) 2010;12:253-60.
55. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ 2004;329:145.
56. Kim AC, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation 2011;124:314-23.
57. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53.
58. Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol 2007;6:94-7.
59. Donnan GA, Hankey GJ, Davis SM. Intracerebral haemorrhage: a need for more data and new research directions. Lancet Neurol 2010;9:133-4.
60. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke, definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
61. O'Donnell M, Xavier D, Diener C, et al. Rationale and design of INTERSTROKE: a global case-control study of risk factors for stroke. Neuroepidemiology 2010;35:36-44.
62. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-23.
63. Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011;42:3651-4.
64. Farooq MU, Chaudhry AH, Amin K, Majid A. The WHO STEPwise approach to stroke surveillance. J Coll Physicians Surg Pak 2008;18:665.
65. Truelsen T, Heuschmann PU, Bonita R, et al. Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke). Lancet Neurol 2007;6:134-9.
66. Sajjad A, Chowdhury R, Felix JF, et al. A systematic evaluation of stroke surveillance studies in low- and middle-income countries. Neurology 2013;80:677-84.
67. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet 2011;377:1438-47.
68. Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 2010;122:406-41.
69. Xu G, Yin Q, Liu X. Narrowing the gap of stroke management between developed and developing countries: report of the Fifth International Stroke Summit, Nanjing, China, July 17-19 2009. Cerebrovasc Dis 2010;29:101-2.
70. Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries. Lancet Neurol 2007;6:553-61.
71. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009;4:CD000213.
72. Durai Pandian J, Padma V, Vijaya P, Sylaja PN, Murthy JM. Stroke and thrombolysis in developing countries. Int J Stroke 2007;2:17-26.
73. Turner-Stokes L, Nair A, Sedki I, Disler Peter B, Wade Derick T. Multi-disciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database Syst Rev 2005;3:CD004170.
74. Wissel J, Olver J, Sunnerhagen KS. Navigating the poststroke continuum of care. J Stroke Cerebrovasc Dis 2013;22:1-8.
75. Fjaertoft H, Rohweder G, Indredavik B. Stroke unit care combined with early supported discharge improves 5-year outcome: a randomized controlled trial. Stroke 2011;42:1707-11.
76. Stavem K, Ronning OM. Survival over 12 years following acute stroke: initial treatment in a stroke unit vs general medical wards. Acta Neurol Scand 2011;124:429-33.
77. O'Rourke K, Walsh C. Impact of stroke units on mortality: a Bayesian analysis. Eur J Neurol 2010;17:247-501.
78. Terent A, Asplund K, Farahmand B, et al. Stroke unit care revisited: who benefits the most? A cohort study of 105,043 patients in Riks-Stroke, the Swedish Stroke Register. J Neurol Neurosurg Psychiatr 2009;80:881-7.
79. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378:1231-43.
80. Yusuf S, Pais P, Afzal R, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341-51.
81. Liu H, Patel A, Brown A, et al. Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk. BMC Public Health 2010;10:458.
82. Rodgers A, Patel A, Berwanger O, et al. An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS One 2011;6:e19857.
83. Wise J. Polypill holds promise for people with chronic disease. Bull World Health Organ 2005;83:885-7.
84. Ellis G, Mant J, Langhorne P, Dennis M, Winner S. Stroke liaison workers for stroke patients and carers: an individual patient data meta-analysis. Cochrane Database Syst Rev 2010;5:CD005066.
85. Marmot MG, Poulter NR. Primary prevention of stroke. Lancet 1992;339:344-7.
86. Marsh JD, Keyrouz SG. Stroke prevention and treatment. J Am Coll Cardiol 2010;56:683-91.
87. Kernan WN, Launer LJ, Goldstein LB. What is the future of stroke prevention? Debate: polypill versus personalized risk factor modification. Stroke 2010;41:S35-8.
88. Kozub E. Community stroke prevention programs: an overview. J Neurosci Nurs 2010;42:143-9.
89. Webster F, Saposnik G, Kapral MK, Fang J, O'Callaghan C, Hachinski V. Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke 2011;42:3176-82.
90. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007;4:CD000197.
91. Outpatient Service Trialists. Therapy-based rehabilitation services for stroke patients at home. Cochrane Database Syst Rev 2003;1:CD002925.
92. Early Supported Discharge Trialists. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev 2005;2:CD000443.
93. Aziz Noor A, Leonardi-Bee J, Phillips Margaret F, Gladman J, Legg Lynn A, Walker M. Therapy-based rehabilitation services for patients living at home more than one year after stroke. Cochrane Database Syst Rev 2008;2:CD005952.
94. Musicco M, Emberti L, Nappi G, Caltagirone C, for the Italian Multicenter Study on Outcomes of Rehabilitation of Neurological Patients. Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil 2003;84:551-8.
95. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-21.
96. Sandeep S, Ganesan A, Mohan V. Development and updation of the Diabetes Atlas of India 2010. Available at: http://www.whoindia.org/LinkFiles/NMH-Resources-Diabetes-atlas.pdf. Accessed March 10, 2012.
97. Pillay TD, Bernabe-Ortiz A, Málaga G, Miranda JJ. Should rural Latin America align to the international diabetes rise forecasts? Diabetes Res Clin Pract 2012;97:e1-2.
98. World Health Organization. Global health risk report 2012. Available at: http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks-report-full.pdf. Accessed March 10, 2012.
99. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.
100. Kawate R, Yamakido M, Nishimoto Y, Bennett PH, Hamman RF, Knowler WC. Diabetes mellitus and its vascular complications in Japanese migrants on the island of Hawaii. Diabetes Care 1979;2:161-70.
101. World Health Organization. Global health risks: mortality and burden of diseases attributable to selected major risks. Available at: http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks-report-full.pdf. Accessed March 10, 2012.
102. World Health Organization. Global Health Observatory. Available at: http://apps.who.int/ghodata/?region=searo. Accessed March 10, 2012.
103. World Health Organization. Non-Communicable Diseases in the South-East Asia Region: Situation and Response. Geneva, Switzerland: World Health Organization; 2011.
104. Diamond J. Diabetes in India. Nature 2011;469:478-9.
105. Ramachandran A. Ching Wan Ma R, Snehalatha C. Diabetes in Asia. Lancet 2010;375:408-18.
106. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008;31:893-8.
107. Ebrahim S, Kinra S, Bowen L, et al, for the Indian Migration Study Group. The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS Med 2010;7:e1000268.
108. Unwin N, James P, McLarty D, et al. Rural to urban migration and changes in cardiovascular risk factors in Tanzania: a prospective cohort study. BMC Public Health 2010;10:272.
109. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev 1997;55:31-43.
110. Deaton A, Drèze J. Nutrition in India: facts and interpretations. Econ Polit Wkly 2009;44:42-65.
111. Finzer L, Ajay VS, Ali MK, et al. Fruit and vegetable purchasing patterns and preferences in south Delhi. Ecol Food Nutr 2013;52:1-20.
112. Kohl HW, Craig CL, Lambert EV, et al. The pandemic of physical inactivity: global action for public health. Lancet 2012;380:294-305.
113. Boffetta P, McLerran D, Chen Y, et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia Cohort Consortium. PLoS One 2011;6:e19930.
114. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 2011;34:1741-8.
115. Marwaha RK, Tandon N, Singh Y, Aggarwal R, Grewal K, Mani K. A study of growth parameters and prevalence of overweight and obesity in school children from Delhi. Indian Pediatr 2006;43:943-52.
116. Bhardwaj S, Misra A, Khurana L, Gulati S, Shah P, Vikram NK. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation. Asia Pac J Clin Nutr 2008;17:172-5.
117. Ramachandran A, Snehalatha C, Vinitha R, et al. Prevalence of overweight in urban Indian adolescent school children. Diabetes Res Clin Pract 2002;57:185-90.
118. Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004;350:865-75.
119. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35:595-601.
120. Victora CG, Adair L, Fall C, et al, for the Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008;371:340-57.
121. Stein AD, Thompson AM, Waters A. Childhood growth and chronic disease: evidence from countries undergoing the nutrition transition. Matern Child Nutr 2005;1:177-84.
122. Norris SA, Osmond C, Gigante D, et al, for the COHORTS Group. Size at birth, weight gain in infancy and childhood, and adult diabetes risk in five low- or middle-income country birth cohorts. Diabetes Care 2012;35:72-9.
123. Bavdekar A, Yajnik CS, Fall CH, et al. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes 1999;48:2422-9.
124. Crowther NJ, Cameron N, Trusler J, Gray IP. Association between poor glucose tolerance and rapid post natal weight gain in seven-year-old children. Diabetologia 1998;41:1163-7.
125. McKeigue PM. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 1989;42:597-609.
126. Bhopal R, Hayes L, White M, et al. Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med 2002;24:95-105.
127. Reddy KS, Prabhakaran D, Jeemon P, et al. Educational status and cardiovascular risk profile in Indians. Proc Natl Acad Sci U S A 2007;104:16263-8.
128. Ajay VS, Prabhakaran D, Jeemon P, et al. Prevalence and determinants of diabetes mellitus in the Indian industrial population. Diabet Med 2008;25:1187-94.
129. Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol 2011;40:804-18.
130. Mohan V, Mathur P, Deepa R, et al. Urban rural differences in prevalence of self-reported diabetes in India-the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract 2008;80:159-68.
131. Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011;33:46-62.
132. Chaturvedi V, Reddy KS, Prabhakaran D, et al. Development of a clinical risk score in predicting undiagnosed diabetes in urban Asian Indian adults. Cardiovasc Dis Prev Control 2008;3:141-51.
133. Ramachandran A, Snehalatha C, Vijay V, Wareham NJ, Colagiuri S. Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract 2005;70:63-70.
134. Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India 2005;53:759-63.
135. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011;343:d7163.
136. Miranda JJ, Bernabe-Ortiz A, Stanojevic S, Malaga G, Gilman RH, Smeeth L. A1C as a diagnostic criteria for diabetes in low- and middle-income settings: evidence from Peru. PLoS One 2011;6:e18069.
137. Nair M, Prabhakaran D, Narayan KM, et al. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes 2011;5:95-102.
138. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: Implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010;87:419-21.
139. Esposito K, Kastorini CM, Panagiotakos DB, Giuliano D. Prevention of type 2 diabetes by dietary patterns: a systematic review of prospective studies and meta-analysis. Metab Syndr Relat Disord 2010;8:143-50.
140. Orozco LJ, Buchleitner AM, Gimenez-Pérez G, et al. Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev 2008;3:CD003054.
141. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
142. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783-9.
143. Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011;54:300-7.
144. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, for the Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-97.
145. Ramachandran A, Snehalatha C, Mary S, et al. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia 2009;52:1019-26.
146. Narayan KMV, Echouffo-Tcheugui JB, Mohan V, Ali MK. Global prevention and control of type 2 diabetes will require paradigm shifts in policies within and among countries. Health Aff (Millwood) 2012;31:84-92.
147. Gæde P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
148. Woodward M, Patel A, Zoungas S, et al. Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial. Diabetes Care 2011;34:2491-5.
149. Mendis S, Al Bashir I, Dissanayake L, et al. Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions. Int J Hypertens 2012;2012:584041.
150. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in sub Saharan Africa 1999-2011: epidemiology and public health implications. a systematic review. BMC Public Health 2011;11:564.
151. Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 2008;94:1376-82.
152. Colagiuri R, Short R, Buckley A. The status of national diabetes programmes: a global survey of IDF member associations. Diabetes Res Clin Pract 2010;87:137-42.
153. Levitt NS, Steyn K, Dave J, Bradshaw D. Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings - insights from South Africa. Am J Clin Nutr 2011;94:1690S-6S.
154. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
155. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
156. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet 2008;372:1473-83.
157. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008;12:703-8.
158. Lamprecht B, McBurnie MA, Vollmer WM, et al, for the BOLD Collaborative Research Group. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011;139:752-63.
159. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-52.
160. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-120.
161. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:1-28.
162. Chan-Yeung M, Aït-Khaled N, White N, Ip MS, Tan WC. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis 2004;8:2-14.
163. Aït-Khaled N, Enarson DA, Ottmani S, El Sony A, Eltigani M, Sepulveda R. Chronic airflow limitation in developing countries: burden and priorities. Int J Chron Obstruct Pulmon Dis 2007;2:141-50.
164. Bousquet J, Kiley J, Bateman ED, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010;36:995-1001.
165. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. Available at: http://www.goldcopd.org. Accessed November 18, 2014.
166. Nelson SB, Lavange LM, Nie Y, et al. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest 2011;142:358-66.
167. Robinson CL, Baumann LM, Gilman RH, et al. The Peru Urban Versus Rural Asthma (PURA) study: methods and baseline quality control data from a cross-sectional investigation into the prevalence, severity, genetics, immunology and environmental factors affecting asthma in adolescence in Peru. BMJ Open 2012;2:e000421.
168. Checkley W, West KP Jr, Wise RA, et al. Maternal vitamin A supplementation and lung function in offspring. N Engl J Med 2010;362:1784-94.
169. Schapira RM, Schapira MM, Funahashi A, McAuliffe TL, Varkey B. The value of the forced expiratory time in the physical diagnosis of obstructive airways disease. JAMA 1993;270:731-6.
170. Straus SE, McAlister FA, Sackett DL, Deeks JJ, for the CARE-COAD2 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease. Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease. J Gen Intern Med 2002;17:684-8.
171. Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax 2010;65:221-8.
172. Torres-Duque C, Maldonado D, Pérez-Padilla R, Ezzati M, Viegi G, for the Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008;5:577-90.
173. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009;374:733-43.
174. Martin WJ II, Glass RI, Balbus JM, Collins FS. A major environmental cause of death. Science 2011;334:180-1.
175. Cynthia AA, Edwards RD, Johnson M, et al. Reduction in personal exposures to particulate matter and carbon monoxide as a result of the installation of a Patsari improved cook stove in Michoacan Mexico. Indoor Air 2008;18:93-105.
176. Edwards RD, Liu Y, He G, et al. Household CO and PM measured as part of a review of China 's National Improved Stove Program. Indoor Air 2007;17:189-203.
177. Ezzati M, Mbinda BM, Kammen DM. Comparison of emissions and residential exposure from traditional and improved cookstoves in Kenya. Environ Sci Technol 2000;34:578-83.
178. Naeher LP, Leaderer BP, Smith KR. Particulate matter and carbon monoxide in highland Guatemala: indoor and outdoor levels from traditional and improved wood stoves and gas stoves. Indoor Air 2000;10:200-5.
179. Bruce N, McCracken J, Albalak R, et al. Impact of improved stoves, house construction and child location on levels of indoor air pollution exposure in young Guatemalan children. J Expo Anal Environ Epidemiol 2004;14:S26-33.
180. Albalak R, Bruce N, McCracken JP, Smith KR, De Gallardo T. Indoor respirable particulate matter concentrations from an open fire, improved cookstove, and LPG/open fire combination in a rural Guatemalan community. Environ Sci Technol 2001;35:2650-5.
181. World Health Organization. WHO air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide - global update 2005. Available at: http://whqlibdoc.who.int/hq/2006/WHO-SDE-PHE-OEH-06.02-eng.pdf. Accessed November 18, 2014.
182. Stanciole AE, Ortegón M, Chisholm D, Lauer JA. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012;344:e608.
183. Asia Pacific COPD Roundtable Group. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology 2005;10:9-17.
184. Weygandt PL, Vidal-Cardenas E, Gilman RH, Avila-Tang E, Cabrera L, Checkley W. Epidemiology of tobacco use and dependence in adults in a poor peri-urban community in Lima, Peru. BMC Pulm Med 2012;12:9.
185. Aït-Khaled N, Auregan G, Bencharif N, et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis 2000;4:268-71.